The American Academy of Anti-Aging Medicine supports new innovative cancer treatments that cause less harm to the body than chemotherapy, radiation, surgery, and other methods

Boca Raton, FL (PRWEB) February 15, 2013

Aetna.com explains that over 1.4 million new cancer cases are diagnosed every year in the United States, 650,000 of which seek chemotherapy (amgen.com). 550,000 people die from cancer each year according to nanomedicinecenter.com. With side effects and death rates from chemo being so extreme, medical experts have turned to other possible methods when threating cancer patients. NCBI.com states that 40 percent of cancer patients turn to complementary and alternative medicine.

Mark Rosenberg MD. has a personal relationship to the disease that jump started vigorous research for a new treatment method. After his mother died from lung cancer, Rosenberg decided to dedicate his time and resources to finding healthier, more innovative methods of cancer treatment.

Rosenbergs innovative treatments consist of immunotherapy, which stimulates the innate immune system. Glycolytic inhibitors prevent cancer cells from utilizing sugar within the body, and inhibit the release of tissue that destroys enzymes.

For over 70 years, chemotherapy has been used to treat cancer. According to an article written by Dr. Rosenberg, chemo adds two or three months onto the estimated survival time. While this method does extend the life expectancy when used in vitro, chemotherapy takes an aggressive toll on a patients internal organs while treated inside the body. Rosenberg developed several methods of new integrative treatment that he found has a more positive effect on the bodys overall well- being as opposed to chemotherapy and radiation.

According to the Academy of Anti-Aging Medicine (A4M), Traditional cancer treatment is efficacious for early stage cancer. Unfortunately, in the U.S., we have made little progress in the treatment of advanced stage cancers in the past twenty years. A study was published in the British journal, "Clinical Oncology," in December, 2004, entitled, "The Contribution of Cytotoxic Chemotherapy to 5-Year Survival in Adult Malignancies." The authors, one medical oncologist and two radiation oncologists, analyzed the results of all randomized clinical trials performed in the U.S. and Australia, that reported a statistically significant increase in 5-year survival due to the use of chemotherapy in adult malignancies. The trials that were analyzed were performed between 1990 and 2004. Overall survival benefit of less than 5% has been achieved in the adjuvant treatment of breast, colon, and head and neck cancers. Clearly, the need for an alternative form of cancer treatment is great and imminent.

On the contrary, I have extended both quality of life and lifespan. Most patients who make their way to my office have already failed chemotherapy and have been told to go home and enjoy their last few months. There is no greater satisfaction than crying with a beautiful forty year-old woman because her metastatic breast cancer to hips and spine is no longer seen on bone scan; or a vibrant sixty seven year-old man with metastases from his kidney to liver, lung, spine, and rib enters remission, after being told by his oncologist that he has perhaps 2 months to live. And this happens over and over, outside of the standard of care, stated Rosenberg.

While traditional cancer treatments do have positive long term effects on some patients, new age innovative treatment methods may be a new option for others who are not so lucky.

A4M hosts one of the first fellowships in integrative cancer therapies. The program is designed to start improving your cancer patients quality of life and survival rates through innovative therapies.

Read more:
Cancer Patients Finding New Treatments are Just as Effective and Less Toxic than Traditional Methods